730
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology, Genetics & Genomic

Transient extra copy of Y chromosome without driver mutation after autologous hematopoietic stem cell transplantation for acute myeloid leukemia: a case report and literature review

, , , , , , , & show all

References

  • Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, Chen PX, Armitage JO. 2013. Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biol Ther. 14:1077–88.
  • Bhatia S. 2013. Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol. 40:666–75.
  • Imrie KR, Dube I, Prince HM, Girouard C, Crump M, Keating A. 1998. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis. Bone Marrow Transpl. 21:395–9.
  • Kato M, Nakasone H, Nakano N, Fuji S, Shinohara A, Yokoyama H, Sakashita K, Hori T, Takahashi S, Nara M, et al. 2020. Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 55:1023–1028.
  • Lambertenghi Deliliers G, Annaloro C, Pozzoli E, Oriani A, Dellavolpe A, Soligo D, Lambertenghi Deliliers D, Tagliaferri E, Bertolli V, Romitti L. 1999. Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation. Leuk Res. 23:291–7.
  • Laurenti L, Chiusolo P, Garzia MG, Zini G, Sora F, Piccirillo N, Piccioni P, Zollino M, Leone G, Sica S. 2002. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies. Haematologica. 87:59–66.
  • Martinez-climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prosper F, Solano C, Garcia Clavel B, Marugan I, Lluch A, Garcia-Conde J. 2000. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome. Bone Marrow Transpl. 25:1203–8.
  • Mcnerney ME, Godley LA, Le Beau MM. 2017. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 17:513–527.
  • Nishikii H, Kurita N, Shinagawa A, Sakamoto T, Kusakabe M, Yokoyama Y, Kato T, Sakata-Yanagimoto M, Obara N, Hasegawa Y, et al. 2019. Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. Case Rep Hematol. 2019:9710790.
  • Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, Weissinger E. 2016. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 7:507.
  • Pedersen-Bjergaard J, Andersen MK, Christiansen DH. 2000. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood. 95:3273–9.
  • Rady K, Blombery P, Westerman DA, Wall M, Curtis M, Campbell LJ, Seymour FJ. 2018. “Reversible” myelodysplastic syndrome or ineffectual clonal haematopoiesis? – add. (6p.) myeloid neoplasm with a spontaneous cytogenetic remission. Leuk Res. 73:1–4.
  • Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, et al. 2020. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 95:799–808.
  • Shao H, Yang Q, Wu C, Cen J, Chen S, Pan J. 2017. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21). Ann Hematol. 96:2127–2129.
  • Singh ZN, Huo D, Anastasi J, Smith SM, Karrison T, Le Beau MM, Larson RA, Vardiman WJ. 2007. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol. 127:197–205.
  • Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman J S. 1994. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood. 84:957–63.